S4 (Andarine)

Description

Andarine, commonly designated S-4 , is a non-steroidal selective androgen receptor modulator (SARM) developed to study tissue-selective activation of the androgen receptor. It has been evaluated primarily in research investigating skeletal muscle biology, bone metabolism, and androgen receptor pharmacology. Unlike anabolic-androgenic steroids, SARMs such as S-4 are designed to selectively activate androgen receptors in specific tissues while minimizing activity in others, although complete tissue selectivity has not been fully established.

S-4 functions by binding to the androgen receptor, a ligand-activated nuclear receptor that regulates the transcription of genes involved in muscle protein metabolism, bone remodeling, and cellular differentiation. Activation of these signaling pathways has been investigated for its effects on lean tissue maintenance, skeletal integrity, and anabolic physiology.

Investigations have examined androgen receptor-mediated regulation of muscle and bone biology, as well as endocrine responses associated with selective receptor modulation. S-4 continues to serve as a research tool for understanding androgen receptor signaling and selective anabolic pharmacology.

Product Specifications 

• Compound / Peptide name: Andarine (S-4)
• Classification: Selective Androgen Receptor Modulator (SARM); non-steroidal androgen receptor agonist
• Sequence (if applicable): Not applicable
• Form: Tablet
• Strength: 25 mg per tablet
• Purity: 99% (supplier specification)
• Appearance: Tablet form
• Storage: Store in a cool, dry place according to supplier recommendations
• Solubility: Research-dependent
• Regulatory Status: Investigational research compound; not approved for human therapeutic use

What Is It Used For and Its Purpose 

S-4 is primarily investigated as a research compound for examining androgen receptor signaling and tissue-selective anabolic activity. Researchers utilize S-4 to explore mechanisms involved in skeletal muscle maintenance, bone physiology, protein metabolism, and endocrine regulation. Experimental models have examined S-4 as a pharmacological tool for understanding how selective androgen receptor activation influences gene transcription associated with muscle remodeling, lean tissue preservation, and bone metabolism. Studies have also investigated its effects on reproductive endocrinology and androgen-responsive tissues. Because S-4 exhibits selective androgen receptor activity, it remains relevant in research exploring nuclear receptor pharmacology and the development of tissue-selective anabolic agents.

Research Application

• Endocrinology
• Androgen receptor signaling
• Skeletal muscle biology
• Bone metabolism
• Molecular pharmacology
• Protein metabolism
• Body composition research
• Reproductive endocrinology

Potential Scientific Benefits 

Investigations have demonstrated that S-4 acts as a selective androgen receptor agonist capable of regulating androgen-responsive gene expression in experimental systems. Laboratory studies have examined its effects on skeletal muscle physiology, lean tissue maintenance, and bone remodeling through androgen receptor-mediated signaling.

Studies have reported anabolic activity involving muscle and bone while exhibiting reduced androgenic effects in certain tissues compared with traditional anabolic steroids. Research has also examined endocrine responses associated with S-4 administration, including effects on the hypothalamic-pituitary-gonadal axis. Additionally, one of the most consistently reported findings is the occurrence of reversible visual disturbances, believed to be related to interactions with receptors in retinal tissue. This characteristic distinguishes S-4 from several other investigational SARMs and remains an important consideration in ongoing pharmacological research.

Claims that S-4 inhibits myostatin, directly suppresses lipoprotein lipase, or produces clinically meaningful fat loss have not been consistently supported by peer-reviewed evidence. Likewise, robust clinical evidence supporting improvements in athletic performance or body recomposition is currently lacking.

Observed biological activities in research

• Selective activation of androgen receptors
• Investigation of anabolic signaling pathways
• Regulation of skeletal muscle protein metabolism
• Effects on bone remodeling in preclinical studies
• Modulation of androgen-responsive gene expression
• Investigation of endocrine regulatory pathways

Molecular mechanisms reported

• Androgen receptor agonism
• Regulation of transcription mediated by androgen receptor activation
• Influence on protein synthesis-related signaling
• Modulation of pathways involved in musculoskeletal physiology

Physiological pathways involved

• Androgen receptor signaling
• Skeletal muscle protein metabolism
• Bone remodeling
• Endocrine feedback regulation

Experimental outcomes in models

• Increased anabolic activity in muscle tissue in animal studies
• Investigation of bone-preserving effects
• Evaluation of tissue-selective androgen receptor activation
• Observation of reversible visual effects in experimental settings

Current evidence remains limited, and further well-controlled clinical studies are required to establish long-term efficacy and safety in humans.

Research Data Sheet 

• Compound / Peptide name: Andarine (S-4)
• Sequence (if applicable): Not applicable
• Classification: Selective Androgen Receptor Modulator (SARM)
• Form: Tablet
• Appearance: Tablet form
• Purity: 99% (supplier specification)
• Solubility: Research-dependent
• Storage: Store in a cool, dry place according to supplier recommendations
• Research Categories: Endocrinology, androgen receptor signaling, skeletal muscle biology, bone metabolism, molecular pharmacology, protein metabolism

Safety Precautions 

S-4 (Andarine) is supplied exclusively for laboratory research and should only be handled by qualified personnel using established laboratory safety procedures. Researchers should also recognize that investigational studies have reported reversible visual disturbances associated with S-4 exposure, while long-term safety and toxicological effects remain incompletely characterized.

• Research use only
• Not for human consumption
• Not intended to diagnose, treat, or prevent disease
• Wear appropriate personal protective equipment, including gloves, laboratory coat, and eye protection
• Follow aseptic laboratory handling procedures where appropriate
• Store under recommended laboratory storage conditions
• Avoid unnecessary freeze–thaw cycles where applicable
• Maintain accurate labeling and documentation
• Dispose of waste according to institutional and regulatory laboratory requirements
• Limited human safety data available
• Potential unknown long-term biological effects

Conclusion 

Andarine (S-4) is an investigational selective androgen receptor modulator that continues to be studied for its role in androgen receptor pharmacology, skeletal muscle biology, and bone metabolism. Its selective interaction with androgen receptors has made it a valuable research compound for exploring tissue-specific anabolic signaling and nuclear receptor function.

While experimental findings demonstrate biological activity involving musculoskeletal and endocrine pathways, the long-term safety profile and clinical relevance of these observations have not been established. S-4 remains an important tool in translational biomedical research aimed at improving the understanding of selective androgen receptor modulation and its physiological consequences.